Wire · regulatory
Congressman Jake Auchincloss on Research Funding, FDA Reform, and U.S. Biotech ...
◆ Sectors
Biotech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 2 September 2026 · Fusion42 review
Congressman Jake Auchincloss discusses the need for steady federal funding of basic biotech research, FDA reform to lower costs for early-stage clinical trials, and maintaining U.S. competitiveness in biotech innovation against global rivals.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
Federal policy shifts aim to reduce FDA barriers and increase research funds, opening windows for early-stage biotech founders to accelerate U.S.-based trials and innovation.
◆ Coverage
1 source · 2 Sep 2026
◆ Related on Wire
◆ Topics
Biotechbiotech-policyfda-reformresearch-fundingclinical-trialsus-competitiveness